# Trade Mark Journal No.2026/032 7 August 2026

## WO0000001909750 (5,42)

Office of origin: United States of America

Date of International Registration:11 February 2026
Date of designation in the UK: 11 February 2026

International priority date claimed: 29 August 2025 (United States of America) (99365805)

Class 5
  Drug delivery agents comprising compounds that facilitate delivery of a wide range of pharmaceuticals and therapeutics; drug delivery agents comprising biological preparations in the nature of non-viral platforms that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics for treatment of diseases and disorders.
Class 42
  Biotechnology research services; research and development of platform technologies for delivery of therapies and pharmaceuticals; scientific, biotechnological, and pharmaceutical research and development for the delivery of therapeutics; scientific, biotechnological, and pharmaceutical research and development regarding delivery of therapeutics.

Voyager Therapeutics, Inc.

Representative: Keith Toms, Esq. McCarter & English, LLP, 265 Franklin Street, Boston MA 02110, UNITED STATES OF AMERICA